DAKAR, Senegal (AP) — The current Ebola outbreak in eastern Congo has escalated into the fastest-growing outbreak in history, claiming over 1,000 lives and leaving more than 2,500 confirmed cases, as health officials scramble to contain the virus. This outbreak, declared on May 15, is particularly concerning as it involves the Bundibugyo virus, which does not have any approved vaccines or treatments available.
According to an update from Congo’s public health institute, there are currently 2,536 confirmed Ebola cases and 1,033 deaths reported, with at least 738 patients either hospitalized or in isolation. Despite indications that the increase in cases may be slowing, health officials warn that the outbreak has not yet peaked. The latest reports highlight sustained transmission, with fluctuations in cases possibly attributed to reporting delays and ongoing data consolidation efforts.
Contact tracing efforts are lagging, as only about 77% of known contacts are being monitored, significantly below the 95% target necessary to effectively interrupt transmission. Additionally, responders face challenges in comprehending the full extent of the outbreak and its potential escalation. Research from the U.S. Centers for Disease Control and Prevention (CDC) suggests that, if conditions worsen, this current outbreak could eclipse previous historical records.
In comparison, the West Africa epidemic of 2014-2016 resulted in over 11,000 deaths, taking about eight months to reach its first 1,000 fatalities. The origins of the current outbreak remain unclear, with most cases emerging from unknown transmission chains according to the World Health Organization (WHO).
The risk of the outbreak expanding globally is considered low; however, the WHO classifies the situation as “very high” within Congo and “high” in Uganda and neighboring countries due to factors such as cross-border spread and population movement. Ebola spreads primarily through direct contact with the bodily fluids of infected individuals, making it less transmissible compared to respiratory viruses. The likelihood of finding additional imported cases is expected as the outbreak continues to develop, but authorities have so far managed to rapidly detect and contain those cases without sustaining transmission beyond the affected region.
Surprisingly, the vast majority of Ebola cases remain confined to Congo, with neighboring Uganda confirming 20 cases, including two fatalities. All these cases are linked to infections imported from Congo, and reports indicate no new cases since June 21. The WHO recently discharged its final patient from the Uganda outbreak, initiating a 42-day countdown for declaring the outbreak over.
Community resistance and mistrust among locals pose substantial challenges in containing the outbreak. Allegations surrounding Ebola treatment centers, fears of isolation, and objections to safe burial practices lead many to avoid testing or seek medical assistance only when critically ill. Furthermore, ongoing conflicts significantly impede surveillance, contact tracing, and access to affected areas, as recent attacks by armed groups have exacerbated the situation.
The Bundibugyo virus's rapid spread complicates response efforts, as no approved preventive measures are available. In response, researchers initiated clinical trials for potential treatments earlier this month, with plans to enroll approximately 1,000 participants in the effort to evaluate the effectiveness of experimental therapies being tested in Ituri province.
As the situation unfolds, it remains crucial for health organizations to address local concerns, enhance community engagement, and improve tracing efforts to stem the tide of this unprecedented Ebola outbreak.
